Overview
Essential Thrombocythemia Plasma | High-Quality Human Plasma from Essential Thrombocythemia (ET) Donors
Essential Thrombocythemia Plasma is collected from donors clinically diagnosed with essential thrombocythemia (ET) and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on inflammatory pathways, immune profiling, and biomarker discovery in ET pathophysiology.
Product Features
- Research Use Only (RUO)
- Plasma collected from clinically confirmed Essential Thrombocythemia (ET) donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
Donor Metadata
- Verified Essential Thrombocythemia (ET) diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional Essential Thrombocythemia (ET)-specific metadata available
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Essential Thrombocythemia plasma is available in standard and custom volumes. For international orders or documentation requirements, please email to ensure compatibility with your country’s regulations.
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.